African American Alzheimer's Progression Markers - CSF and Neuro-Imaging

CompletedOBSERVATIONAL
Enrollment

135

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Mild Cognitive ImpairmentAlzheimer's Disease
Interventions
PROCEDURE

Lumbar puncture

Cerebrospinal fluid (CSF) will be collected via lumbar puncture. During lumbar puncture, a needle is inserted between two lumbar bones (vertebrae) to remove a sample of cerebrospinal fluid. The procedure involves inserting a thin, hollow needle between the two lower vertebrae (lumbar region), through the spinal membrane (dura) and into the spinal canal and extracting a small amount of fluid. The procedure takes about 45 minutes.

PROCEDURE

Blood draw

One tube of blood will be collected in an ethylenediaminetetraacetic acid (EDTA)-K2 plasma tube for DNA analysis.

PROCEDURE

Magnetic Resonance Imaging (MRI)

Each participant will undergo Magnetic Resonance Imaging (MRI) analysis using a modified Alzheimer's Disease Neuroimaging Initiative (ADNI) protocol with a 3 Tesla (3T) MRI Scan. The exam takes approximately 20 minutes.

Trial Locations (1)

30322

Emory University, Atlanta

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Emory University

OTHER

NCT02089555 - African American Alzheimer's Progression Markers - CSF and Neuro-Imaging | Biotech Hunter | Biotech Hunter